Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
Nanalysis Scient Rg (Canada Venture Exchange)
Závěr k 13.2.2026 Změna (%) Změna (CAD) Objem obchodů (CAD)
0,15 -6,25 -0,01 -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiNanalysis Scientific Corp
TickerNSCI
Kmenové akcie:Ordinary Shares
RICNSCI.V
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2023 130
Akcie v oběhu k 05.02.2026 138 454 331
MěnaCAD
Kontaktní informace
UliceUnit 105, 90 Freeport Boulevard NE
MěstoCALGARY
PSČT3J 5J9
ZeměCanada
Kontatní osoba 
Funkce kontaktní osoby 
Telefon14 037 699 499
Fax14037756683

Business Summary: Nanalysis Scientific Corp. is a global manufacturer and seller of compact magnetic resonance imaging (MRI) and spectroscopy products. Its segments include Scientific Equipment and Security Services. The Scientific Equipment segment conducts scientific equipment manufacturing and sales, primarily as a patent-protected technology company that develops, manufactures, and sells magnetic resonance (MR) products for education, pharmaceutical, biotech, nutraceutical, chemical, food, materials, security, life science and medical applications. The Security Services segment focuses on providing security services, namely providing preventative and on-call maintenance services, as well as installation of detection and analysis equipment. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. The Company's devices are used in industries, including chemical, mining, pharma, and others.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Nanalysis Scientific Corp revenues decreased 11% to C$29.5M. Net loss decreased 20% to C$4.9M. Revenues reflect Scientific Equipment segment decrease of 33% to C$9.3M, Europe (Region) segment decrease of 80% to C$948K, Other segment decrease of 56% to C$370K, Asia (Region) segment decrease of 14% to C$482K. Lower net loss reflects Security Services segment income increase of 13% to C$1M.
Odvětvová klasifikace
TRBC2012Advanced Medical Equipment & Technology (NEC)
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSAnalytical Laboratory Instrument Manufacturing
NAICS2007Electromedical Apparatus Mfg
NAICS2007Analytical Laboratory Instrument Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Analytical Laboratory Instrument Manufacturing
SICElectromedical Equipment
SICAnalytical Instruments



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerSean Krakiwsky-04.06.2019
Interim Chief Financial Officer, Corporate ControllerHeather Kury-05.12.202505.12.2025
Chief Technology OfficerJulien Mueller-27.04.202127.04.2021
Vice President Marketing and Product ManagerSusanne Riegel-
Vice President - Product DevelopmentNeal Gallagher-
Vice President - Corporate Services & StrategyHeather Phillips-